Valuation Freenome, Inc.

Stocks

End-of-day quote Nasdaq 10/09/2026			5-day change	1st Jan Change
14.79 ^USD	-6.10%		-9.32%	+13.51%

08-20	Guggenheim Initiates Freenome at Buy With $21 Price Target	MT
08-19	Freenome Registers Up To 75.2 Million Shares For Sale	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2025	2026	2027	2028
Market Cap ¹	144.2	1,544	-	-
Change	-	970.67%	-	-
Enterprise Value (EV)	144.2	1,544	1,544	1,544
Change	-	970.67%	0%	0%
P/E	-1.57x	-7.29x	-6.43x	-6.33x
PBR	-	-	-	-
PEG	-	0.1x	-0.5x	-3.86x
Capitalization / Revenue	-	15.1x	13.6x	7.42x
EV / Revenue	-	15.1x	13.6x	7.42x
EV / EBITDA	-	1,716x	-8.73x	-9.26x
EV / EBIT	-	-13.3x	-7.19x	-8.99x
EV / FCF	-	-11.5x	-9.68x	-26.4x
FCF Yield	-	-8.69%	-10.3%	-3.79%
Dividend per Share ²	-	-	-	-
Rate of return	-	-	-	-
EPS ²	-8.28	-1.97	-2.233	-2.27
Distribution rate	-	-	-	-
Net sales ¹	-	102.4	113.8	208.1
EBITDA ¹	-	0.9	-176.8	-166.7
EBIT ¹	-	-116.1	-214.8	-171.8
Net income ¹	-219.3	-175.1	-245.7	-257.7
Net Debt	-	-	-	-
Reference price ²	13.03	14.37	14.37	14.37
Nbr of stocks (in thousands)	11,068	107,447	-	-
Announcement Date	3/30/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
FREENOME, INC.	-7.29x	-	-	-	1.54B
IOVANCE BIOTHERAPEUTICS, INC.	-18x	9.04x	-18.02x	-.--%	3.9B
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-44.43x	12.97x	833.96x	-.--%	3.86B
VERACYTE, INC.	36.87x	4.59x	16.85x	-.--%	3.29B
CAREDX, INC.	23.73x	-	-	-	2.6B
BGI GENOMICS CO., LTD.	132.85x	-	-	-	2.05B
SEEGENE, INC.	16.25x	1.98x	6.94x	3.64%	1.07B
MARAVAI LIFESCIENCES HOLDINGS, INC.	-21.24x	5.04x	31.54x	-.--%	971M
Average	14.84x	6.73x	174.25x	0.73%	2.41B
Weighted average by Cap.	10.33x	8.21x	247.89x	0.3%